Impact of Bendamustine Treatment Before Apheresis on Outcomes in Patients With LBCL Receiving CAR T-Cell Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy
J. Clin. Oncol 2023 Oct 24;[EPub Ahead of Print], G Iacoboni, V Navarro, AÁ Martín-López, K Rejeski, M Kwon, KA Jalowiec, P Amat, JL Reguera-Ortega, L Gallur, V Blumenberg, S Gutiérrez-Herrero, C Roddie, A Benzaquén, J Delgado-Serrano, MA Sánchez-Salinas, R Bailén, C Carpio, L López-Corral, R Hernani, M Bastos, M O'Reilly, L Martín-Martín, M Subklewe, P BarbaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.